Drug solubility classification in the bovine.

Area of Science:

• Veterinary pharmacology
• Drug development
• Ruminant physiology

Background:

• Current drug solubility testing relies on human pharmaceutical data.
• Significant physiological differences exist between ruminant and monogastric gastrointestinal tracts.
• These differences impact the suitability of existing solubility test conditions and criteria for cattle.

Purpose of the Study:

• To highlight critical differences in ruminant versus monogastric gastrointestinal physiology.
• To discuss how these differences affect drug solubility classification in cattle.
• To propose alternative perspectives for modifying solubility criteria for ruminants.

Main Methods:

• Comparative analysis of gastrointestinal tract characteristics.
• Discussion of factors including stomach pH, volume, oral formulation types, and 'highest dose' definition.
• Review of existing human pharmaceutical solubility guidelines.

Main Results:

• Ruminant gastrointestinal physiology presents unique challenges for standard solubility testing.
• Factors such as pH, volume, and formulation type necessitate a species-specific approach.
• The definition of 'highest dose' requires re-evaluation for ruminant drug products.

Conclusions:

• Existing human-derived solubility criteria are not directly applicable to cattle.
• Modification of solubility test conditions and criteria is necessary for accurate drug classification in ruminants.
• Further research into ruminant-specific parameters is recommended.